 |
|
U of Minnesota researcher discovers the starting point of sun-induced skin cancer
May 15, 2008According to a new study from the University of Minnesota, the earliest event in the development of sun-induced skin cancer may have been identified. The researchers found that the point of entry for skin cancer in response to sun exposure is in receptor molecules, molecular "hooks" on the outer surface of cells that also pull cannabinoid compounds found in marijuana out of the bloodstream. The research appears in the May 15 issue of Cancer Research.
"The question at the core of this research was, 'Why does ultraviolet light induce skin cancer?'" said lead researcher Zigang Dong, a professor of cellular and molecular biology and director of the university's Hormel Institute, which supported the study. "The idea is to find an agent that can prevent skin cancers after exposure to the sun."
The researchers found that two receptors for cannabinoids also responded to UV light. They made the discovery during a search for the initial interaction between UV light and human skin cells.
The researchers began their search with plant cells because plants must interact with UV light in order to harness its energy for photosynthesis. They concluded that the UV receptors in plants ought to be similar to any found in humans, and, therefore, the genes for the plant and human receptors must also be similar. When they compared plant genes for UV receptors to human genetic material, they found that the human genes for cannabinoid receptors matched.
If cannabinoid receptors are important in the initiation of skin cancer by UV light, then animals that lack the receptors should be relatively protected from the ravages of the light. Working with mouse embryos, the researchers removed the genes for the cannabinoid receptors. They found that the skin of the resulting adult mice, which lacked the receptors, was resistant to the development of UV-induced inflammation and skin tumors called papillomas.
Also, when they exposed cannabinoid receptors to UV light, the receptors changed from an inactive to an active state, indicating they had absorbed and responded to the light.
Why should evolution have produced receptors that respond to both UV light and cannabinoids"
"That we don't know," said Dong.
University of Minnesota
Cannabinoid Receptor Current Events and Cannabinoid Receptor News RSSImpact of cannabis on bones changes with age, study finds
Scientists investigating the effects of cannabis on bone health have found that its impact varies dramatically with age.
New cannabis-like drugs could block pain without affecting brain, says study
A new type of drug could alleviate pain in a similar way to cannabis without affecting the brain, according to a new study published in the journal Pain on Monday 15 September.
Opioids and cannabinoids influence mobility of spermatozoids
A PhD thesis from the University of the Basque Country has concluded that there are opioid and cannabinoid receptors in human sperm and that these influence the mobility of spermatozoid.
New Mount Sinai research tracks effects of addictive drugs on brain
Mount Sinai researchers may have unlocked the key to better understanding the effect addictive drugs have on the human brain.
MIT study suggests caution on new anti-obesity drug in kids
Anti-obesity drugs that work by blocking brain molecules similar to those in marijuana could also interfere with neural development in young children, according to a new study from MIT's Picower Institute for Learning and Memory.
The endocannabinoids: Functional roles and therapeutic opportunities
Cannabis (marijuana) is the most widely produced plant-based illicit drug worldwide and the illegal drug most frequently used in Europe. Its use increased in almost all EU countries during the 1990s, in particular among young people, including school students.
Obese heart attack patients are more likely to survive after treatment than normal weight patients
Obese and very obese patients have a lower risk of dying after they have been treated for heart attacks than do normal weight patients, according to research published in the European Heart Journal.
Endogenous cannabinoids linked to fetal brain damage imposed by maternal cannabis use
A critical step in brain development is governed by endogenous cannabinoids, 'the brain's own marijuana'.
Study shows enzyme builds neurotransmitters via newly discovered pathway
The new study describes a pathway-different than the one previously suggested-for the biosynthesis of neurotransmitter lipids, N-acyl ethanolamines (NAEs), which include the endogenous cannabinoid ("endocannabinoid") anandamide.
Marijuana-like compounds suppress the immune response
A group of Japanese scientists has discovered that cannabinoids can cause some white blood cells to lose their ability to migrate to the sites of infection and inflammation.
More Cannabinoid Receptor Current Events and Cannabinoid Receptor News Articles
 |
The Cannabinoid Receptors (The Receptors) by Patricia H. Reggio (Editor) As research has progressed, the cannabinoid CB 1 and CB 2 receptors have expanded significantly in importance within the neuroscience mainstream. In The Cannabinoid Receptors, leading experts introduce newcomers to the cannabinoid field with chapters covering cannabinoid ligand synthesis and structure activity relationships, the molecular pharmacology of the cannabinoid receptors and the endocannabinoid system, and ultimately, the whole animal pharmacology and therapeutic applications for cannabinoid drugs. Adding to those key topics, the book also examines the current direction of the field with chapters on new putative cannabinoid receptors and challenges for future research. As a part of The Receptors ™ series, this volume highlights its receptor with the most thorough, focused... |
 |
Cannabinoids (Handbook of Experimental Pharmacology) (Volume 168) by Roger G. Pertwee (Editor) The present book is an outstanding summary of many aspects of cannabinoid research. It provides current knowledge about the pharmacology and therapeutic potential of cannabinoids as well as knowledge about the pharmacology, physiology, and pathology of the endogenous cannabinoid systems. The chapters are written by scientists who have made or are still making major contributions to the field. This book may well help generate novel ideas on how to approach the study of emotions. |
 |
Cannabinoids and the Brain by Attila Köfalvi (Author), Attila Köfalvi (Editor) Endocannabinoids control most of the body functions, and in the brain, they modulate neurotransmission, synaptic plasticity, confer neuroprotection, control metabolism, neuro- and neuritogenesis, survival, cognitive and motor functions as well as a plethora of other higher-order brain functions. Their fruitful therapeutic potential is recognized by cannabinoid researchers and pharmaceutical companies, respectively. The aim of this book is to help clinicians, neuroscientists, as well as students, understand the significance of the endocannabinoid system. This book, however, also will be very useful to those who already feel comfortable with the neuroscience of endocannabinoids. The book will introduce the reader to the up-to-date neurobiology of endocannabinoids and related... |
|
Cannabinoid Receptors (Neuroscience Perspectives) by Roger Pertwee (Editor), Peter Jenner (Editor) The Neuroscience Perspectives Series provides multidisciplinary reviews in one of the most diverse and rapidly advancing fields in the life sciences. The recent discovery of cannabinoid receptors and endogenous cannabinoid receptor ligands begins an exciting new phase of cannabinoid research. These studies will extend beyond the realms of pharmacology and molecular biology into the realms of physiology and pathophysiology. Research in this area will lead to a betterunderstanding of how the body functions in both health and disease and will aid in developing new medicines. By bringing together the most recent research in this area and by focusing on possible future developments, Cannabinoid Receptors aims to stimulate much needed input from a wide range of disciplines. | |
|
CeNeRx BioPharma Awarded New Patent for its Innovative Compounds That Selectively Target Peripheral Cannabinoid Receptors.: An article from: BIOTECH Patent News by Unavailable (Author) This digital document is an article from BIOTECH Patent News, published by Biotech Patent News on March 1, 2009. The length of the article is 596 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available immediately after purchase. You can view it with any web browser. Citation Details Title: CeNeRx BioPharma Awarded New Patent for its Innovative Compounds That Selectively Target Peripheral Cannabinoid Receptors. Author: Unavailable Publication: BIOTECH Patent News (Newsletter) Date: March 1, 2009 Publisher: Biotech Patent News Volume: 23 Issue: 3 Distributed by Gale, a part of Cengage... | |
|
Synthesis of Novel Cannabinoid CBI Receptor Ligands by Teija Parkkari (Author) English-language text. 148 pp. | |
 |
Insights into Receptor Function and New Drug Development Targets (Research and Perspectives in Endocrine Interactions) by Michael Conn (Editor), C. Kordon (Editor), Y. Christen (Editor) We are now on the verge of viewing effector molecules and other regulatory sites as therapeutic targets for the amelioration of human and animal disease. The recognition, for example, that mutant proteins are frequently misrouted molecules, rather than functionally defective ones, changes our approach to "inborn errors of metabolism" and offers new approaches for pharmacological discovery, based on rescue of receptors, ion channels and enzymes with pharmacoperones. Ion channels, regulators of G-protein signaling and enzymes engaged in regulation, now present opportunities for drug development. The state of our art also benefits by the availability of superior tools that allow measurement of interactions and afford unprecedented insight into the biomolecular interactions that present novel... |
|
Old drugs in new role: relieving chronic pruritus; Cannabinoid agonists, opioid receptor antagonists have attracted the attention of dermatologists.(Across ... An article from: Clinical Psychiatry News by Patrice Wendling (Author) This digital document is an article from Clinical Psychiatry News, published by Thomson Gale on December 1, 2005. The length of the article is 584 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser. Citation Details Title: Old drugs in new role: relieving chronic pruritus; Cannabinoid agonists, opioid receptor antagonists have attracted the attention of dermatologists.(Across Specialties) Author: Patrice Wendling Publication: Clinical Psychiatry News (Magazine/Journal) Date: December 1, 2005 Publisher: Thomson Gale Volume: 33 Issue: 12 Page: 63(1) Distributed by Thomson... | |
|
Competitor Analysis: Cannabinoid CB1 receptor antagonists by La Merie S.L. (Author) The Competitive Intelligence Report Cannabinoid-1 (CB1) Receptor Antagonists as of November 2008 provides a competitor analysis in the development pipeline of novel CB1 receptor antagonists for treatment of obesity, type 2 diabetes and CNS diseases. First generation cannabinoid type 1 (CB1) receptor antagonists are directed against CB1 receptors in the brain and in peripheral tissues such as adipocytes. Acomplia (rimonabant) from Sanofi-Aventis is the only representative of this class of CB1 antagonists so far approved. While the FDA rejected approval due to an unfavourable risk-benefit ratio, The EMEA first approved it, but only for treatment of obesity. Quite recently, the CHMP of the EMEA recommended to suspend marketing of Acomplia due to an increased... | |
 |
Endocannabinoids: The Brain and Body's Marijuana and Beyond by Emmanuel S Onaivi (Editor), Takayuki Sugiura (Editor), Vincenzo Di Marzo (Editor) Over the past decade, there have been major advances in understanding the mechanisms whereby marijuana interacts with the brain in producing psychoactive and potentially therapeutic effects. The discovery of specific gene coding for cannabinoid receptors activated by smoking marijuana, and the finding of endogenous cannabinoids, which also activate the receptors, have transformed cannabinoid research into mainstream science with significant implications in human health and disease Endocannabinoids: The Brain and Body’s Marijuana and Beyond documentsadvances in the discovery and functioning of naturally occurring marijuana-like substances in human biology. It explores recent findings that point to the existence of an endocannabinoid physiological control system (EPCS) that... |
| © 2009 BrightSurf.com |